VAERS reports by lot

GSK Varicella/Shingles lot AC79X: VAERS reports

76 VAERS reports list lot AC79X as a GSK Varicella/Shingles vaccine, received between 2019-06-29 and 2020-09-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
76
Reports
4%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction7226%
General / Systemic (non-local)6524%
Dermatological (non-injection-site)3714%
Neurological259%
Musculoskeletal238%
Gastrointestinal228%
Allergic / Anaphylactic176%
Cardiac / Cardiovascular83%
Respiratory31%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Ohio11
New York6
Maine5
Pennsylvania5
Indiana5
California4
Utah4
North Carolina3
Massachusetts3
Virginia3
New Hampshire2
Louisiana2

Reports by month received

2019-062
2019-0740
2019-0811
2019-098
2019-105
2019-114
2019-122
2020-012
2020-021
2020-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.